Revolutionizing Cell Immunotherapies with Serum Free T Cell Media

CAR T Cell Therapy Shows Promise for Treating Several Applications Pharma Tech Outlook interviewed our CEO Scott Deeter, who shares how InVitria is revolutionizing T cell immunotherapies. InVitria offers the experience and expertise to help you supplement your media of choice with its full line of animal-free, serum-free, recombinant individual cell-culture components. If you would …